Lazard Asset Management LLC Boosts Stock Position in Align Technology, Inc. $ALGN

Posted by Geri Gentry on Aug 2nd, 2026

Lazard Asset Management LLC lifted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 34.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,212 shares of the medical equipment provider’s stock after buying an additional 4,643 shares during the quarter. Lazard Asset Management LLC’s holdings in Align Technology were worth $3,122,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ALGN. Sunbelt Securities Inc. grew its stake in Align Technology by 222.4% in the 4th quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 109 shares during the period. Blue Trust Inc. raised its position in Align Technology by 77.5% during the first quarter. Blue Trust Inc. now owns 158 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 69 shares during the period. Independence Bank of Kentucky raised its position in Align Technology by 77.7% during the fourth quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares during the period. Tobam purchased a new position in Align Technology during the fourth quarter valued at $30,000. Finally, Hollencrest Capital Management purchased a new position in Align Technology during the first quarter valued at $34,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 2.5%

Align Technology stock opened at $169.16 on Friday. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $200.43. The firm has a market capitalization of $12.12 billion, a price-to-earnings ratio of 29.42, a PEG ratio of 1.73 and a beta of 1.67. The company has a fifty day simple moving average of $174.55 and a 200-day simple moving average of $175.21.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating analysts’ consensus estimates of $2.62 by $0.02. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the business earned $2.49 earnings per share. On average, research analysts anticipate that Align Technology, Inc. will post 9.48 EPS for the current fiscal year.

Align Technology declared that its board has authorized a share buyback program on Wednesday, April 29th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 1.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Wall Street Analyst Weigh In

ALGN has been the subject of a number of research reports. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research note on Thursday. UBS Group restated a “neutral” rating and set a $189.00 price target on shares of Align Technology in a research report on Thursday, July 23rd. Morgan Stanley lifted their price objective on Align Technology from $169.00 to $188.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Citigroup initiated coverage on Align Technology in a research note on Wednesday, April 15th. They set a “buy” rating and a $240.00 price objective for the company. Finally, Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Align Technology presently has an average rating of “Moderate Buy” and a consensus target price of $206.36.

View Our Latest Analysis on ALGN

Align Technology Company Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.